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Abstract
The Mycobacterium tuberculosis (MTB) membrane is rich in antigens that are potential targets for 
diagnostics and the development of new vaccines. To better understand the mechanisms 
underlying MTB virulence and identify new targets for therapeutic intervention we investigated 
the differential composition of membrane proteomes between virulent M. tuberculosis H37Rv 
(MTB) and the Mycobacterium bovis BCG vaccine strain. To compare the membrane proteomes, 
we used LC-MS/MS analysis in combination with label-free quantitative (LFQ) proteomics, 
utilizing the area-under-curve (AUC) of the extracted ion chromatograms (XIC) of peptides 
obtained from m/z and retention time alignment of MS1 features. With this approach, we obtained 
relative abundance ratios for 2,203 identified membrane-associated proteins in high confidence. 
Of these proteins, 294 showed statistically significant differences of at least 2 fold, in relative 
abundance between MTB and BCG membrane fractions. Our comparative analysis detected 
several proteins associated with known genomic regions of difference between MTB and BCG as 
being absent, which validated the accuracy of our approach. In further support of our label-free 
quantitative data, we verified select protein differences by immunoblotting. To our knowledge we 
have generated the first comprehensive and high coverage profile of comparative membrane 
proteome changes between virulent MTB and its attenuated relative BCG, which helps elucidate 
the proteomic basis of the intrinsic virulence of the MTB pathogen.
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Tuberculosis remains a major world health problem with Mycobacterium tuberculosis, the 
bacterium responsible for this disease, claiming 1.4 million lives annually1. Exacerbating 
this problem is the rise in multidrug-resistant (MDR), extensively drug-resistant (XDR) and 
most recently, totally drug-resistant (TDR) strains of M. tuberculosis, which threaten to 
undermine current tuberculosis treatments2. The currently available tuberculosis vaccine, 
known as BCG, is an attenuated strain of Mycobacterium bovis. All M. bovis strains, 
including BCG, are very similar to M. tuberculosis exhibiting 99.9% identity at the DNA 
level3. Unfortunately, the ability of BCG vaccination to protect adults from pulmonary 
tuberculosis is highly variable4. Thus, there is a major need to develop new drugs and 
vaccines to control tuberculosis and a better understanding of M. tuberculosis biology will 
help achieve this goal.
Many aspects of M. tuberculosis physiology, pathogenesis, and immunity remain to be 
understood. Comparisons of virulent M. tuberculosis to attenuated M. bovis BCG can inform 
on these unknowns. Genomic comparisons reveal several regions of difference (named RDs) 
that are deleted in BCG but present in M. tuberculosis5. Proteomic comparisons of M. 
tuberculosis and BCG are another approach for identifying differences of potential 
importance. By reporting on protein abundance, proteomic methods have the advantage of 
taking into account both transcriptional and post-transcriptional effects. Further, when 
combined with subcellular fractionation, proteomics can report on protein localization. M. 
tuberculosis and BCG proteomes were initially compared using 2-dimensional gel 
electrophoresis (2D-GE) followed by mass spectrometry-based identification of select 
proteins6–8. At best, this approach led to the identification of almost 300 proteins6, 9. Since 
then, quantitative “shotgun” proteomics has become the choice for large scale proteome 
comparisons, which enables more comprehensive assessment of complex protein samples as 
a result of higher throughput and sensitivity associated with this method10, 11.
Proteins localized to the membrane of M. tuberculosis play critical roles in vital cell 
processes including nutrient transport, cell wall synthesis, energy metabolism, and signal 
transduction12–14. Additionally, mycobacterial membrane proteins can elicit immune 
responses, making the membrane proteomes of M. tuberculosis and BCG of significant 
interest for vaccination and diagnostic studies15. Initial efforts to identify the M. tuberculosis 
and BCG membrane proteome used 2D-GE; however, the high insolubility of membrane 
proteins poses a significant technical challenge for 2D-GE and limits the numbers of 
proteins that can be identified16, 17. Significantly better protein identification coverage was 
subsequently obtained when membrane proteins were solubilized and pre-separated by 1D 
SDS-PAGE followed by LC-MS/MS analysis of trypsin digested gel slices comprising the 
entire sample18. Using this approach in independent studies, 349 and 739 proteins out of the 
possible 4,015 proteins encoded by the genome were identified in M. tuberculosis 
membrane fractions prepared by differential centrifugation18, 19. With BCG a similar effort 
involving Triton X-114 fractions, which enriches for lipophilic proteins including 
hydrophobic membrane proteins, identified 351 proteins and 1,766 M. tuberculosis proteins 
were identified in Triton X-114 fractions20. Triton X-114 can be considered an alternative to 
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differential centrifugation for enriching membrane and membrane-associated proteins20. 
While the number of proteins identified in mycobacterial membrane proteins has increased 
considerably18, 19, there has yet to be an in-depth quantitative comparison of M. tuberculosis 
and BCG membrane protein composition.
In the study reported here, we combined SDS-solubilization and 1D SDS-PAGE separation 
of membrane proteins with LC-MS/MS and label-free quantitative proteomics, to 
comprehensively identify and compare the membrane fraction proteomes of the virulent M. 
tuberculosis H37Rv strain (MTB) and M. bovis BCG. With this approach, we identified a 
total of 2,203 proteins associated with the mycobacterial cytoplasmic membrane. Further, 
label-free quantification (LFQ) revealed 294 proteins that differed significantly in relative 
abundance, by at least 2-fold, between MTB and BCG. Several proteins encoded by deleted 
RD regions of BCG were identified as missing in BCG, which validated our approach. The 
quantitative differences in membrane proteins identified in this work have potential to help 
explain the deficiencies in the BCG vaccine and to inform on virulence and immunogenic 
features of M. tuberculosis. The data reported here should aid efforts to develop new 
tuberculosis control and preventative measures.
Experimental Procedures
M. tuberculosis and M. bovis BCG growth conditions
Mycobacterium tuberculosis H37Rv (MTB) and Mycobacterium bovis BCG Pasteur were 
grown at 37° C in liquid Middlebrook 7H9 medium (Difco) supplemented with 0.05% 
Tween 80, 0.5% glycerol, and 1X ADS [>0.5% bovine serum albumin, 0.2% glucose, 0.85% 
NaCl]. Two independent 100 mL cultures of each strain were grown to an OD600 of 1, when 
cells were then harvested by centrifugation and washed with phosphate-buffered saline 
(PBS). For removal from BSL-3 containment, the washed pellets were sterilized by gamma-
irradiation in a JL Shephard Mark I 137Cs irradiator (Dept. of Radiobiology, University of 
North Carolina at Chapel Hill).
Cytoplasmic membrane fraction preparation
Cytoplasmic membrane fractions were isolated by centrifugation as previously described18. 
Briefly, cells suspended in PBS containing a cocktail of protease inhibitors were lysed by 
passage through a french press cell. Unlysed cells were removed by centrifugation at 3,000 
× g and the clarified whole cells lysates were spun at 27,000 × g for 30 minutes to remove 
the cell wall fraction. The supernatant was then spun at 100,000 × g for 2 hours to isolate the 
cytoplasmic membrane fraction. Membrane fractions were washed once, suspended in PBS, 
and proteins concentrated using an Amicon Ultra centrifugation filter with a 10 kD pore size 
(Millipore). Protein concentrations were determined by BCA assay (Pierce) using a BSA 
standard and equalized among both strains and all replicates.
Separation and in-gel digestion of membrane proteins
For label-free quantitative proteomics experiments, two biological replicates of MTB and 
BCG membrane proteins were separated on a 12% reducing SDS-PAGE gel. For each 
sample, 8.8 mg of protein was loaded in an individual lane for separation. The protein bands 
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were visualized by Coomassie Blue R-250 staining (Bio-Rad, Hercules, CA) and protein 
bands for each biological sample were cut into 10 equivalent gel slices, approximately 2 mm 
thick. Trypsin digestion of the excised gel slices was performed as previously described21 
with modifications. Briefly, each gel slice was cut into smaller pieces and placed in a single 
well of a 96-well U-bottom polypropylene plate. After de-staining with acetonitrile (ACN), 
slices were incubated in 25 mM ammonium bicarbonate (ABC) containing 20 µg/mL of 
sequencing-grade trypsin overnight at 37° C. The digest supernatants were transferred to a 
new 96-well plate. Tryptic peptides were extracted from the gel slices by two washes with 
50% ACN. The ACN washes were added to the ABC wash in the fresh plate. Digested 
peptides were store at −80° C until lyophilization.
Liquid Chromatography-Tandem Mass Spectrometry and Protein Identification
In gel digested peptides were desalted using PepClean C18 spin columns (Pierce, Rockford, 
IL), used according to the manufacturer’s instructions, and re-suspended in an aqueous 
solution of 0.1% formic acid. Identification of proteins was done using reversed-phase LC-
MS/MS on a 2D-nanoLC Ultra system (Eksigent Inc, Dublin, CA) coupled to an LTQ-
Orbitrap Velos mass spectrometer (Thermo Scientific, San Jose, CA). The Eksigent system 
was configured to trap and elute peptides via a sandwiched injection of ~ 250 fmol of 
sample. The trapping was performed on a 3 cm-long 100 µm i.d. C18 column while elution 
was performed on a 15 cm-long 75 µm i.d., 5 µm, 300Å particle ProteoPep II integraFrit 
C18 column (New Objective Inc, Woburn, MA). Analytical separation of the tryptic 
peptides was achieved with a 70-min linear gradient of 2–30% buffer B at a 200 nL/min, 
where buffer A is an aqueous solution of 0.1% formic acid and buffer B is a solution of 
0.1% formic acid in acetonitrile.
Mass spectrometric data acquisition was performed in a data-dependent manner on a hybrid 
LTQ-Orbitrap velos mass spectrometer. A full scan mass analysis on an Orbitrap (externally 
calibrated to a mass accuracy of < 1 p.p.m and a resolution of 60,000 at m/z 400) was 
followed by intensity-dependent MS/MS of the 10 most abundant peptide ions. High energy 
collision dissociation (HCD) was used to dissociate peptides with normalized collision 
energy of 35 eV. The MS/MS acquisition of each precursor m/z was repeated for 30 s and 
subsequently excluded for 60 s. Monoisotopic precursor ion selection (MIPS) and charge 
state screening were enabled for triggering data-dependent MS/MS scans. All 10 gel slices 
of each of the two biological replicates of MTB and BCG strains were subjected to three 
independent LC-MS runs (three technical replicates for each of the two biological 
replicates), resulting in the production of 120 LC-MS runs. Mass spectra were processed, 
and peptide identification was performed using Andromeda search engine found in 
MaxQuant software ver. 2.2.1. (Max Planck Institute, Germany) All protein database 
searches were performed against the M. tuberculosis H37Rv protein sequence database 
(RefSeq NC_000962 uid57777) downloaded from National Center for Biotechnology 
Information (NCBI)22. This database contained 4,018 annotated proteins and the sequences 
were derived from the H37Rv ASM19595v2 assembly. Peptides were identified with a 
target-decoy approach using a combined database consisting of reverse protein sequences of 
the H37Rv and common repository of adventitious proteins (cRAP). The cRAP database 
was obtained from the Global Proteome Machine (GPM) ftp site (ftp://ftp.thegpm.org/fasta/
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cRAP). Peptide identification was made with a false discovery rate (FDR) of 1% (10) while 
peptides were assigned to proteins with a protein FDR of 5%. A precursor ion mass 
tolerance of 20 ppm was used for the first search that allowed for m/z retention time 
recalibration of precursor ions that were then subjected to a main search using a precursor 
ion mass tolerance of 5 ppm and a product ion mass tolerance 0.5 Da. Search parameters 
included up to two missed cleavages at KR on the sequence (11), and oxidation of 
methionine as a dynamic modification. All MTB and BCG protein identifications are 
reported with a posterior error probability (PEP) ≤ 0.1 and filtering of reverse and 
contaminant proteins.
Protein Quantitation
Label-free quantitation was based on peak area23, 24. The measured area under the curve 
(AUC) of m/z and retention time aligned extracted ion chromatogram (XIC) of a peptide 
was performed via the label-free quantitation module found in MaxQuant [ver. 1.2.2.5]. All 
six replicates (biological and technical replicates) of each strain, with 10 LC-MS runs each, 
were included in the LFQ experimental design with protein-level quantitation and 
normalization performed using unique and razor peptide features corresponding to 
identifications filtered with a peptide FDR of 0.01, and protein FDR of 0.05. The MaxQuant 
protein groups and evidence files were processed, stored in an MS-Access database and 
statistical analysis and visualization was performed using Perseus [ver. 1.2.0.17] (Max 
Planck Institute, Germany) and JMP genomics (SAS, Cary NC). Relative quantification 
changes between MTB and BCG in replicate data was performed using t-test statistics with a 
p-value < 0.05. The quantitative data was reported with t-test differences between MTB and 
BCG and corresponding p-values and estimation of false discovery rates (FDR) using q-
values25 for both raw and normalized LFQ intensities and LFQ intensities that were imputed 
in replicated runs using a Gaussian distribution with a width of 0.3 and downshift of 1.8 as 
the imputation parameters26.
Immunoblotting of membrane proteins
For both replicates of MTB or BCG, 30 µg of clarified whole cell lysate (WCL), was 
separated on a 12% SDS-PAGE gel. Membrane fractions (MEM) obtained from 30 µg of 
WCL were also loaded in independent lanes to visualize subcellular localization of the 
protein. For the Icl1 immunoblot, 60 µg of membrane fraction was loaded, and 
approximately 0.5 µg of recombinant Icl1 protein27 (rIcl) was included as a control to 
identify the appropriate protein species. Proteins were transferred to a nitrocellulose 
membrane (Whatman) then detected using either anti-Icl1 (provided by David Russell) at 
1:5,00027, anti-GlcB (provided by Suman Laal) at 1:2,50028, anti-SigA (provided by Murty 
Madiraju) at 1:20,00029, or anti-19kDa (provided by Douglas Young) at 1:20,000. Anti-
mouse and anti-rabbit secondary antibodies conjugated to alkaline phosphatase (BioRad) 
were used as appropriate at a concentration of 1:20,000. Signal was detected using ECF 
reagent (GE Healthcare).
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Our understanding of why the BCG vaccine is attenuated or fails to elicit optimal protection 
against M. tuberculosis infection remains incomplete. Using quantitative “shotgun” 
proteomics, we set out to identify the composition of the membrane proteomes of attenuated 
BCG and virulent MTB and compare the relative abundance of the individual proteins in the 
two strains.
Identification of the MTB and BCG membrane proteome
To generate comprehensive and accurate lists of the M. tuberculosis and BCG membrane 
proteomes, we isolated membrane fractions from two biological replicates of M. 
tuberculosis H37Rv (MTB) and M. bovis BCG cultures by differential ultra-centrifugation 
of cell lysates. Membrane proteins were subjected to SDS-solubilization, separated by 1D 
SDS-PAGE, and then analyzed by LC-MS/MS.
Proteins were identified in MTB and BCG membrane fractions from six replicates (two 
biological replicates of each species, each with three technical replicates) using MaxQuant 
and label-free quantification design, where each biological group was subjected to a protein 
sequence database search against a concatenated database consisting of H37Rv protein 
entries. A total of 2,203 proteins were identified in high confidence using the target-decoy 
approach with a peptide FDR cut-off of 0.01 (Supplemental Table 1). In addition, a protein 
FDR cut-off of 0.05 was employed. Figure 1A shows the reproducibility of the proteins 
identified between replicates. Analysis of the first set of MTB and BCG biological samples 
revealed 1,371 proteins that were identified in all three technical replicates, while 
comparison of the second set of biological samples revealed 1,270 common identifications 
across all technical replicates. Of the 2,203 total proteins, 1,760 were identified with a 
minimum of 2 peptides per protein in any one of the six runs (See Supplemental Table 1). In 
MTB there were 2,003 proteins identified and in BCG 2,009 proteins, with the majority of 
proteins identified in a strain being identified in all six replicates (Figure 1B). Figure 1C 
shows that a majority of the proteins (1,809 out of 2,203) were identified in both MTB and 
BCG while 194 proteins were only identified in MTB and 200 proteins were unique to BCG. 
When the same comparison is run with the proteins identified with a minimum of 2 peptides 
in any one of the six runs, 1,389 out of 1,760 proteins were identified in both MTB and 
BCG, while 181 proteins were only identified in MTB and 190 proteins only in BCG.
Of the 2,203 total proteins identified in the membrane fractions of MTB and/or BCG, 26% 
(580) are predicted to have a transmembrane domain for integration into the cytoplasmic 
membrane or a cleavable signal peptide for export across the cytoplasmic membrane (Figure 
2). 440 proteins have putative transmembrane domains predicted by the TMHMM 
algorithm30. 140 proteins are predicted by SignalP31 or TatP32 to contain either Sec or Tat 
export signal peptides, which would target them for export across the cytoplasmic 
membrane by one of the corresponding conserved protein export systems33. Of the proteins 
with signal peptides, 54% contain a lipobox in the signal peptide that predicts the proteins 
become lipidated during the process of export34. We identified 75 out of the almost 100 
predicted lipoproteins of M. tuberculosis H37Rv35. The relatively high number of potential 
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lipoproteins detected in the membrane fractions is consistent with the established role of 
lipid modification in anchoring proteins to the membrane36.
Interestingly, however, the majority of proteins identified in the membrane fraction lacked 
transmembrane domains and/or signal peptides. Previous mass spectrometry studies have 
similarly identified a population of proteins lacking export signals in mycobacterial 
cytoplasmic membrane fractions prepared by the differential centrifugation method we used 
here, as well as with Triton X-114 fractionation19, 37. Some of these proteins lacking export 
signals and/or transmembrane domains may be cytoplasmic proteins that are peripherally 
associated with phospholipids in the membrane or integral membrane proteins. 
Alternatively, they may represent mycobacterial membrane proteins that lack predicted 
signals for localization. A final possibility is that these proteins lacking predicted export 
signals are cytoplasmic contaminants that are detected by the high sensitivity of mass 
spectrometry.
These 2,203 proteins that we identified can be broadly divided into several functional 
categories (Figure 3)38. In addition to a large list of conserved hypothetical proteins of 
unknown function, the majority of the proteins we identified in the membrane have 
predicted roles in cell wall processes, lipid metabolism, and intermediary metabolism. This 
pattern of functional category enrichment is similar to a previous proteomic analysis of the 
M. tuberculosis membrane19, 20, 39.
Label-free quantitation and comparison of M. tuberculosis and BCG membrane proteomes
Label-free quantification (LFQ) was performed across all biological samples and replicates 
via alignment of retention-time and m/z features that were detected at the MS1 level. Using 
the MaxQuant software, the area-under-the curve (AUC) of each extracted peptide ion 
chromatogram was used to compute the LFQ intensities at the peptide and protein levels for 
each biological replicate. This analysis led to relative abundance ratios for 1,788 proteins. 
We also analyzed the data with imputation of missing values in order to generate abundance 
ratios and statistics for all 2,203 proteins identified. Imputation provides a means of 
statistical correction for missing values by calculating what could have been derived 
experimentally26. We defined significant differences (p ≤ 0.05) in protein levels in MTB 
versus BCG using a t-test. Using this criterion, the majority of proteins showed no 
significant difference in relative abundance between MTB and BCG (Figure 4A). 
Supplement Table 4 lists the 294 proteins with significant differences and a log2 BCG/MTB 
ratio of ±1 or greater (representing differences > 2-fold) before and after missing value 
imputation (191 of these proteins were significant without imputation). These 294 proteins 
include 188 proteins (139 without imputation) that were lower in BCG and 106 after missing 
value imputation (85 without imputation) that were present at higher levels in BCG 
compared to MTB. Figure 4B shows a prototypical correlation analysis between the 
quantitative ratios between BCG and MTB. The good orthogonal fit between the data 
reveals good reproducibility between replicate runs with a Pearson’s correlation coefficient 
of 0.8
Given the genomic identity between M. tuberculosis and BCG of >99.9%, 294 proteins 
(after missing value imputation) with statistically significant differences of at least 2-fold 
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may seem high. However, it is not too much of a surprise when considering the deleted 
genomic RD regions of BCG5, 40 (discussed below) and >2000 SNPs between BCG and M. 
tuberculosis3. In addition, a prior study comparing differential gene expression at the level 
of transcripts between M. tuberculosis and M. bovis (the virulent parent of BCG) reported 
6% of the total genome showing differential expression5, 40, 41. Further, the potential for a 
single protein alteration/disruption to affect numerous proteins in a pathway is a real 
possibility. The proteins on our stringent lists of differences include interesting examples of 
proteins with roles in lipid and intermediary metabolism, cell wall processes, and transport 
systems (Tables 1). There are additionally many conserved hypothetical proteins that differ 
between the strains. Review of the proteins on these lists also revealed cases in which the 
relative abundance of multiple proteins encoded in the same genomic region was altered 
similarly. In these cases, where the corresponding genes are located in operons or under the 
control of the same promoter it is likely the proteomic differences reflect transcriptional 
differences between strains. Among such examples, is an interesting group of three proteins 
encoded by neighboring genes that are part of a polyacyltrehalose (PAT) biosynthesis locus 
(rv1180–rv1183) and a genomic locus encoding components of the ESX-3 specialized 
secretion system (rv0282–rv0292) (Figure 5).
Validation of differences detected between MTB and BCG membrane proteomes
As one way to validate the accuracy of our proteomic approach to identify proteins that 
differ between MTB and BCG, we searched our datasets for proteins encoded by the RD 
deletion regions of BCG. From a total of 132 genes that have been mapped to the 14 RD 
deletion regions of BCG Pasteur40, we identified peptides mapping to 36 RD proteins in 
MTB, 24 of which were identified with ≥2 peptides per protein. As expected, all RD-
associated proteins identified in MTB were absent in BCG, reflecting deletion of the 
corresponding genes in the BCG strain (Table 1). When quantified with LFQ, the RD 
proteins had extremely low values with imputation as expected (Supplement Table 4).
We also experimentally validated differences in protein abundance by immunoblotting. 
However, this analysis was limited to proteins for which we could obtain antibodies. We 
evaluated a set of representative proteins that were either increased in BCG, decreased in 
BCG, or equal between the BCG and MTB membrane proteomes. We analyzed whole cell 
lysates (WCL) and the corresponding membrane (MEM) fractions prepared from MTB and 
BCG, to look for protein level differences comparable to our mass spectrometry data (Figure 
6).
The M. tuberculosis housekeeping sigma factor SigA (rv2703) is primarily a cytoplasmic 
protein, but small amounts were detected in membrane fractions. This protein was relatively 
unchanged between the MTB and BCG membranes using our label-free analysis (log2 
BCG/MTB = 0.759, p = 0.555 after imputation). Using an anti-SigA antibody we found 
similar amounts of SigA protein in membrane fractions from both strains, confirming the 
mass spectrometry finding (Figure 6). As an example of a protein under-represented in the 
BCG membrane in comparison to MTB, we chose the LpqH lipoprotein (19kDa lipoprotein, 
Rv3763), which is a potent M. tuberculosis antigen42. Our LFQ data for LpqH, although not 
significant (p = 0.178) had a BCG/MTB log2 ratio of −2.955. Immunoblotting was 
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consistent and revealed that the amount of LpqH was reduced in the BCG membrane 
compared to the MTB membrane. The reduced amount of LpqH in BCG was also evident 
when comparing whole cell lysates of the two strains.
We also evaluated two proteins that were significantly increased in abundance in the BCG 
membrane: isocitrate lysase Icl1 [rv0467, log2(BCG/MTB) = 3.52, p = 0.025] and malate 
synthase GlcB [rv1837c, log2(BCG/MTB) = 2.10, p = 0.051]. Our immunoblotting analysis 
detected Icl1 and GlcB in the membrane of BCG but little to no protein in the membrane of 
MTB (Figure 6). Interestingly, the amount of Icl1 was also higher in the whole cell lysate of 
BCG but the levels of GlcB in whole cell lysates appeared equivalent. These data highlight 
an advantage of proteomic comparisons of subcellular fractions, which is the ability to 
identify both localization differences of proteins that appear equally expressed between 
strains, such as GlcB, as well as changes in total protein abundance that consequently results 
in less protein at the membrane, such as LpqH and Icl1. Taken together, our validation 
efforts support our results using a label free quantitative proteomic approach to compare 
mycobacterial proteomes.
Discussion
Tuberculosis remains a major world health problem. Unfortunately, BCG is the only 
tuberculosis vaccine currently available and it demonstrates highly variable and incomplete 
protection against adult pulmonary tuberculosis. There is a need to develop improved 
vaccines and there is also a need to better understand the virulence properties of M. 
tuberculosis in order to develop new drugs to treat tuberculosis. A better understanding of 
the differences between the attenuated BCG vaccine and M. tuberculosis will aid these 
efforts.
Comparative genomics has revealed several differences at the chromosomal level between 
BCG and MTB, but these strains have yet to be compared using large scale comparative 
proteomics strategies. Quantitative “shotgun” proteomics allows for determining the relative 
abundance of large numbers of proteins between strains. Furthermore, the use of label-free 
quantification is a simple method for assessing relative quantities of proteins between 
samples that does not require additional chemistries or sample preparation. This is 
particularly ideal for slow-growing organisms such as M. tuberculosis, which may not be 
easily amendable to metabolic labeling.
So far, label-free quantitative proteomics have only been applied in a handful of studies of 
M. tuberculosis, but are producing encouraging results with enhanced coverage of the 
mycobacterial proteome37, 43, 44. However, this approach had yet to be extended to a direct 
comparison of the BCG vaccine and virulent MTB. In applying this method to our study 
here, we quantified significantly more proteins (2,203) than past studies involving 2D gel 
comparisons of M. tuberculosis and BCG, which yielded between 200 and 300 
proteins6, 8, 45. We measured relative abundances for a large number of proteins, including 
191 (296 after imputation) proteins with statistically significant (p≤0.05) and protein 
abundance differences of 2-fold or more. It is also interesting to compare the total number of 
proteins we identified in this study to the total number of proteins identified in a Triton 
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X-114 fraction of M. tuberculosis by Malen et al. (2011)37, which represents an alternate 
membrane protein enrichment strategy to the fractionation scheme we used. Of the 1,575 M. 
tuberculosis proteins identified in the Triton X-114 fraction, 71% of them were also 
identified in our study. However, 44% of the 2,003 H37Rv proteins we identified were not 
identified in the prior Malen et al. study (data not shown). Thus, our report provides 
important confirmation for many proteins as being membrane associated while also 
identifying additional examples. The differences can likely be attributed to the different 
membrane enrichment protocols used. Importantly, the differential centrifugation method is 
widely used to prepare membrane fractions in M. tuberculosis research46.
Importantly, all our efforts to validate our proteomic analysis gave consistent results, which 
provide confidence in the previously unknown differences identified in our study. We were 
able to detect changes in LpqH, Icl1, and GlcB proteins, which were predicted by the mass 
spectrometry data to differ between BCG and MTB membranes. We also identified RD 
region-associated proteins in the MTB membrane that were undetected in the BCG 
membrane as expected. Along with the proteins encoded in RD regions, SigK (rv0445) is 
another protein we expected to find significantly reduced in BCG. SigK is a sigma factor 
known to have a point mutation in its start codon in BCG47. In MTB the SigK start codon is 
ATG, but in BCG it is ATA which reduces translation efficiency in BCG. Our LFQ analysis 
showed that SigK was reduced in the BCG membrane [log2 (BCG/MTB) = −4.872, p = 
1.6×10−4], which is consistent with the protein being reduced in abundance in BCG. It is 
important to recognize that label-free quantification is a discovery tool for initial hypothesis 
generation. For proteins that do not have antibodies or other orthogonal testing methods that 
are highly quantitative, accurate quantification will require stable isotope dilution mass 
spectrometry methods such as SRM (selected reaction monitoring), which could be used as a 
verification assay.
When quantitated by LFQ, the RD region-associated proteins had extremely low values with 
imputation. Other proteins with very large changes in LFQ abundance (either low or high) 
could represent other examples of strain-specific proteins. In fact, there were 178 proteins 
for which ≥ 2 peptides was identified in at least 4 out of 6 replicates of the BCG membranes 
samples, but no corresponding peptides were identified in any MTB replicate (Supplemental 
Table 2). Alternatively, 186 proteins were only identified in MTB using the same criteria 
(Supplemental Table 3).
It will also be particularly interesting to follow up on proteins that were significantly more 
abundant or only identified in the pathogenic MTB membrane (i.e. less abundant or 
undetected in BCG), as candidates for virulence factors, antigens, or explaining physiologic 
differences between the strains. We identified 294 proteins that were at least 2-fold 
difference in abundance in the MTB membrane at p ≤ 0.05 (Supplemental Table 4). 
Furthermore, there were 186 proteins that were only identified in MTB by at least 2 peptides 
in 4 of 6 runs with no corresponding peptides identified in any BCG replicate (Supplemental 
Table 3). These proteins would be leading candidates for roles in these processes.
Among the interesting examples of proteins with reduced levels in BCG versus MTB were a 
group of three proteins encoded by neighboring genes that are part of a polyacyltrehalose 
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(PAT) biosynthesis locus (rv1180–rv1183). For Rv1179c, Rv1180/Pks3 and Rv1181 Pks4, 
these proteins were present at significantly lower levels in BCG versus MTB (Figure 6A). 
Rv1180/Pks3 and Rv1181/Pks4 (also known as Msl3) comprise a polyketide synthase 
needed to synthesize the mycolipenic side chains of PAT.48, 49Interestingly, PAT is a 
surface lipid only found in pathogenic mycobacteria49, 50 but the explanation for the PAT 
deficiency in BCG Pasteur has remained unknown3. Our data suggests it is due to deficiency 
in the PAT biosynthetic machinery. Rv1179c is a protein of unknown function and not 
currently thought to function in PAT biosynthesis but its similar behavior in BCG suggests it 
might also have a role in PAT biosynthesis.
Another set of proteins that are reduced or absent in the BCG membrane proteome versus 
that of MTB are components of the ESX-3 specialized secretion system, which is encoded 
by a genomic locus, including Rv0282/EccA3, Rv2083/EccB3, Rv0284/EccC3, Rv0289/
EspG3, Rv0290/EccD3, Rv0291, and Rv0292/EccE3 (Figure 6B). The ESX-3 system is 
essential in M. tuberculosis with an apparent function in iron and zinc homeostasis51, 52. In 
addition, a role for ESX-3 in eliciting protective immunity against M. tuberculosis was 
recently reported. In mouse studies, vaccination with a non-pathogenic M. smegmatis strain 
engineered to express the M. tuberculosis ESX-3 locus elicited better protection against M. 
tuberculosis challenge than BCG53. While the role of ESX-3 in this protection is not clear, 
one possibility is that some ESX-3 components are protective antigens. To our knowledge, 
our study is the first to show that levels of ESX-3 in BCG are reduced compared to M. 
tuberculosis, which raises the interesting possibility that the vaccination efficacy of BCG 
could be improved by increasing the levels of the ESX-3 system.
Also of interest are proteins that were more abundant in the BCG membrane compared to 
that of MTB, as they may provide insight into the adaptive changes that BCG has undergone 
that influence virulence and immunogenicity. We identified several proteins involved in the 
TCA and glyoxylate shunt pathways that were statistically more abundant in the BCG 
membrane. The significance of this result is unclear although it suggests a difference in 
metabolic activity between BCG and M. tuberculosis, at least in our growth conditions. 
Among the group of proteins that are more abundant in BCG were both of the mycobacterial 
isocitrate lyases: Icl1 [Rv0467, log2 (BCG/MTB) = 3.523, p = 0.025] and AceA [Rv1915/
Rv1916, log2 (BCG/MTB) = 2.104, p = 0.051]. In MTB, both of these isocitrate lyases are 
required for survival in a mouse model of infection54. In line with our observations of higher 
Icl levels in BCG, we also detected increased GlcB malate synthase, an enzyme that 
participates along with isocitrate lyase in the glyoxylate shunt. Because the glyoxylate shunt 
is required for mycobacteria to utilize fatty acids as carbon sources, which are believed to be 
the primary carbon source for MTB during infection, it would be interesting to determine if 
these observations reflect any differences in fatty acid metabolism between BCG and MTB, 
which could influence growth in the host.
In conclusion, we used a label-free quantitative approach to compare protein abundance in 
different species of mycobacteria. Not only did this work greatly expand the number of 
proteins that have been compared between BCG and M. tuberculosis, it identified many 
differences at the protein level that were not predicted from genomic comparisons. 
Comparison to the RD regions of the genome and immunoblot analysis supports the 
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accuracy of our data for proteins showing significant differences in abundance between 
MTB and BCG. Among the proteins identified are new candidates for understanding the 
well-established but poorlyunderstood differences between M. tuberculosis and BCG.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Total proteins identified in the M. tuberculosis (MTB) and M. bovis BCG membrane 
fractions
(A) Mass spectrometry analysis of membrane fractions derived from either M. tuberculosis 
(MTB) or M. bovis BCG (BCG) resulted in the high-level of reproducibility in three 
technical runs for each of the two biological replicates with biological replicate 1 showing 
1,371 identifications in all three technical replicates while biological replicate 2 shows 1,270 
identifications in all three technical replicates. (B) Proteins identified in all six runs were 
categorized on the basis of the number of replicates they were identified, for all proteins in 
Gunawardena et al. Page 16













MTB, BCG, or both strains. (C) Protein identifications in MTB and BCG using 1 peptide 
per protein criteria in any of the six runs and ≥ 2 peptides per protein criteria
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Figure 2. Membrane-associated proteins with predicted export signal peptides or 
transmembrane domains
The primary amino acid sequence of the 2,203 total proteins identified in the membrane 
fractions of MTB and BCG were analyzed for the presence of aminoterminal export signal 
peptides or transmembrane domains. A total of 440 proteins contain probable 
transmembrane domains predicted by the TMHMM 2.030 (omitting TMHMM 
transmembrane predictions likely representing N-terminal signal peptides). Additionally, 
140 proteins are predicted by SignalP31 or TatP32 to contain either Sec or Tat export signal 
peptides, which would target them for export out of the cytoplasm by conserved bacterial 
secretion machinery. Of the 140 proteins with putative export signals, 54% are possible 
lipoproteins with lipobox motifs in their signal peptides predicted by LipoP34 or by using a 
lipoprotein pattern search against the M. tuberculosis H37Rv genome35.
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Figure 3. Functional categories of proteins identified in MTB and/or BCG
The 2,203 proteins identified in both biological replicates of either M. tuberculosis H37Rv 
or M. bovis BCG represented several functional categories.
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Figure 4. Label-free quantification of proteins from M. tuberculosis (MTB) and M. bovis BCG
(A) To identify proteins with differences in abundance between the membranes of MTB and 
BCG, a label-free quantification analysis based on peak area was performed. The measured 
area under the curve of m/z and retention time aligned extracted ion chromatogram of each 
peptide was performed via the label-free quantitation module found in MaxQuant [ver. 
1.2.2.5]. We obtained relative abundance ratios for 2,203 proteins (black diamonds), shown 
here plotted by BCG/MTB ratio (log2 scale) and pvalue (−log10 scale). Of these shared 
proteins, 294 were statistically different (p≤0.05, t-test) in abundance between strains by 2-
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fold or more yellow squares). Proteins with LFQ ratios confirmed by immunoblot are shown 
as red circles (SigA-levels unchanged) and (LpqH-lower level in BCG, albeit not 
significant). Also labeled are proteins under-represented in the BCG that correspond to PAT 
synthesis (blue diamonds) and the ESX-3 secretion system (green squares). (B) The 
correlation between log2 (BGG/MTB) ratios obtained from two biological replicates of 
MTB and BCG. Nonparemetric quantile densities are shown between the two replicates with 
an orthogonal fit
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Figure 5. Genomic loci encoding proteins less abundant in the M. bovis BCG membrane 
compared to M. tuberculosis H37Rv (MTB) membrane
Among the differences observed between the MTB and BCG membrane proteomes were 
proteins involved in polyacyltrehalose (PAT) biosynthesis (A) and specialized protein 
secretion via the ESX-3 system (B). Genes encoding proteins that were determined by LFQ 
analysis to be under-represented in BCG are shaded in black or grey and the corresponding 
log2(BCG/MTB) ratio is provided (imputed values). Those genes shaded black encode 
proteins whose LFQ ratios had p values of 0.05 or less.
Gunawardena et al. Page 22













Figure 6. Immunoblot confirmation of relative protein abundances between the M. tuberculosis 
H37Rv and M. bovis BCG membrane fractions
The same membrane fractions (MEM) used for MS analysis were also analyzed by 
immunoblot using antibodies against four representative proteins. Also included are the 
whole cell lysates (WCL) from which the corresponding membrane fractions were derived. 
The isocitrate lysase Icl1 and malate synthase GlcB represent proteins that were 
significantly reduced in the BCG membrane as determined by our MS analysis. The sigma 
factor SigA produced a label-free quantitation log2(BCG/MTB) ratio of 0.759 with a p value 
of 0.555, indicating no difference in abundance between the strains. The LpqH lipoprotein 
was determined to be lower in abundance in the BCG membrane than MTB (−2.995) albeit 
with a p value of 0.178.
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